SEC Form 4 · accession 0001209191-18-026609
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Parini
Officer — EVP, CL&AO
Period of report
Apr 25, 2018
Accepted (ET)
Apr 27, 2018 · 4:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 25, 2018 | M | 2,125 | $90.29 | A | 42,123 | D | |
| Common StockF2,F3 | Apr 25, 2018 | S | 2,214 | $155.07 | D | 39,909 | D | |
| Common StockF3,F4 | Apr 25, 2018 | S | 300 | $156.36 | D | 39,609 | D | |
| Common Stock | Apr 26, 2018 | M | 38,250 | $122.45 | A | 77,859 | D | |
| Common StockF3,F5 | Apr 26, 2018 | S | 38,250 | $159.56 | D | 39,609 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F6 | $90.29 | Apr 25, 2018 | M | 2,125 | D | — | Jul 11, 2026 | Common Stock | 2,125 | 19,125 | D |
| Stock Option (Right to Buy)F7 | $122.45 | Apr 26, 2016 | M | 38,250 | D | — | Jan 3, 2026 | Common Stock | 38,250 | 29,750 | D |
Explanation of responses
- F1Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
- F2Open market sales reported on this line occurred at a weighted average price of $155.07 (range $154.61 to $155.56).
- F3Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- F4Open market sales reported on this line occurred at a weighted average price of $156.36 (range $155.97 to $156.75).
- F5Open market sales reported on this line occurred at a weighted average price of $159.56 (range $159.51 to $159.60).
- F6The option vests in 16 quarterly installments from 7/12/2016.
- F7The option vests in 16 quarterly installments from 1/4/2016.